Prognostic and Predictive Biomarkers in Familial Breast Cancer
Large numbers of breast cancers arise within a familial context, either with known inherited germline mutations largely within DNA repair genes, or with a strong family history of breast and/or ovarian cancer, with unknown genetic underlying mechanisms. These cancers appear to be different to sporad...
Main Authors: | Siddhartha Deb, Anannya Chakrabarti, Stephen B. Fox |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/4/1346 |
Similar Items
-
<i>BRCA1/2</i> Serves as a Biomarker for Poor Prognosis in Breast Carcinoma
by: Tong Yi Jin, et al.
Published: (2022-03-01) -
Hereditary Breast Cancer in Romania—Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country
by: Andreea Cătană, et al.
Published: (2023-05-01) -
Pathogenic <i>BRCA</i> Variants as Biomarkers for Risk in Prostate Cancer
by: Ciara S. McNevin, et al.
Published: (2021-11-01) -
Double Heterozygosity for Rare Deleterious Variants in the <i>BRCA1</i> and <i>BRCA2</i> Genes in a Hungarian Patient with Breast Cancer
by: László Madar, et al.
Published: (2023-10-01) -
No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in <i>BRCA1</i> or <i>BRCA2</i> Mutation Families
by: Marion Imbert-Bouteille, et al.
Published: (2021-07-01)